In the BioHarmony Drug Report Database
Eteplirsen
Exondys (eteplirsen) is an oligonucleotide pharmaceutical. Eteplirsen was first approved as Exondys on 2016-09-19. It is used to treat duchenne muscular dystrophy in the USA. Exondys 51’s patents are valid until 2034-03-14 (FDA).
Trade Name
|
Exondys |
|---|---|
Common Name
|
eteplirsen |
ChEMBL ID
|
CHEMBL2108278 |
Indication
|
duchenne muscular dystrophy |
Drug Class
|
Antisense oligonucleotides |
Image (chem structure or protein)
